Related Experiment Video
Updated: Sep 9, 2025

08:49
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
Published on: May 11, 2018
9.5K
Total Artificial Heart vs Left Ventricular Assist Device and Biventricular Assist Device.
1Division of Cardiothoracic Surgery, Department of Surgery, University of Minnesota, Minneapolis, Minnesota.
Seminars in Thoracic and Cardiovascular Surgery
|August 28, 2025
Summary
Biventricular heart failure is a complex challenge, often leading to right ventricular failure with durable left ventricular assist devices (LVADs). Practice patterns are shifting for mechanical circulatory support and heart transplantation, with AI potentially accelerating advancements.
Area of Science:
- Cardiology and Mechanical Circulatory Support
- Heart Transplantation and Artificial Organs
Background:
- Biventricular heart failure presents significant challenges in end-stage cardiomyopathy patients.
- Right ventricular failure is a major complication of durable left ventricular assist devices (LVADs), impacting patient outcomes.
- Evolving heart transplant allocation systems influence the use of mechanical circulatory support.
Purpose of the Study:
- To review current practice patterns in mechanical circulatory support for biventricular failure.
- To discuss strategies for bridge to heart transplantation in patients with complex heart failure.
- To highlight challenges in direct device comparisons and the potential role of artificial intelligence.
Main Methods:
- Review of current literature and practice patterns regarding mechanical circulatory support devices (ECMO, temporary VADs, durable VADs).
- Analysis of strategies for managing biventricular failure in the context of heart transplantation.
- Discussion of challenges in device implementation and the potential impact of emerging technologies.
Main Results:
- Significant shifts in practice patterns for mechanical circulatory support in biventricular failure.
- Difficulties in direct device comparisons due to provider and institutional learning curves.
- The field is rapidly evolving, with potential for artificial intelligence to accelerate progress.
Conclusions:
- Biventricular heart failure management requires careful consideration of mechanical circulatory support options.
- Right ventricular failure remains a critical concern with durable LVADs.
- Continued evolution and technological advancements, including AI, are expected in this field.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
32
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
32
Heart Failure VI: Adjunct Therapies
27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27
Hemodialysis I: Introduction
282
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
282

